{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:35:12Z","timestamp":1794270912551,"version":"4.9.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Histotripsy is a noninvasive, nonionizing, nonthermal ablation technology approved by the US FDA for liver cancer treatment in 2023. It exerts antitumor effects via focused ultrasound cavitation, with unique immunomodulatory advantages. Core mechanisms include inducing immunogenic cell death to form an \u201cin situ vaccine,\u201d reshaping tumor microenvironment immune cell infiltration, regulating cytokine networks, and triggering a CD8\u2005+\u2005T cell-mediated ferroptosis-related \u201cabscopal effect.\u201d Combined with immune checkpoint inhibitors, antiangiogenic drugs, or chemotherapy, it shows significant synergistic efficacy. Clinical trials such as #HOPE4LIVER confirm its 95% technical success rate in hepatocellular carcinoma. With further optimization, Histotripsy is expected to benefit more solid tumor patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049082","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:56Z","timestamp":1780718516000},"page":"e49082","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Research progress on the antitumor immune regulation mechanisms and combined treatment strategies of histotripsy: A review"],"prefix":"10.1097","volume":"105","author":[{"given":"Xv","family":"Sun","sequence":"first","affiliation":[{"name":"Clinical Medical College of Jiamusi University, Jiamusi, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1416-1829","authenticated-orcid":false,"given":"Fanbo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Physical Diagnosis, The First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260711","doi-asserted-by":"crossref","first-page":"e000200","DOI":"10.1136\/jitc-2019-000200","article-title":"Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy.","volume":"8","author":"Qu","year":"2020","journal-title":"J ImmunoTher Cancer"},{"key":"R2-20260711","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.3390\/jcm14186391","article-title":"Surgery without scalpel: histotripsy as a non-invasive and non-thermal modality for liver tumor ablation.","volume":"14","author":"Paramythiotis","year":"2025","journal-title":"J Clin Med"},{"key":"R3-20260711","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1097\/MS9.0000000000001897","article-title":"Histotripsy: an innovative approach for minimally invasive tumour and disease treatment.","volume":"86","author":"Iqbal","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"R4-20260711","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2174\/0115733947330950240906075443","article-title":"Histotripsy: a promising modality for cancer treatment.","volume":"21","author":"Parashar","year":"2025","journal-title":"Curr Cancer Ther Rev"},{"key":"R5-20260711","doi-asserted-by":"crossref","first-page":"708810","DOI":"10.3389\/fonc.2021.708810","article-title":"Local destruction of tumors and systemic immune effects.","volume":"11","author":"Tranberg","year":"2021","journal-title":"Front Oncol"},{"key":"R6-20260711","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/cancers17060915","article-title":"The emerging role of histotripsy in liver cancer treatment: a scoping review.","volume":"17","author":"Queen","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R7-20260711","doi-asserted-by":"crossref","first-page":"792781","DOI":"10.3389\/fimmu.2021.792781","article-title":"Combination of ablation and immunotherapy for hepatocellular carcinoma: where we are and where to go.","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"R8-20260711","doi-asserted-by":"crossref","first-page":"105054","DOI":"10.1016\/j.critrevonc.2025.105054","article-title":"Immunoresistant to immunosensitive - Histotripsy\u2019s unique potential to overcome resistance.","volume":"217","author":"Kim","year":"2026","journal-title":"Crit Rev Oncol Hematol"},{"key":"R9-20260711","doi-asserted-by":"crossref","first-page":"2297650","DOI":"10.1080\/02656736.2023.2297650","article-title":"Insights from in vivo preclinical cancer studies with histotripsy.","volume":"41","author":"Worlikar","year":"2024","journal-title":"Int J Hyperth"},{"key":"R10-20260711","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/cancers17020183","article-title":"Ultrasound-guided histotripsy triggers the release of tumor-associated antigens from breast cancers.","volume":"17","author":"Tang","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R11-20260711","doi-asserted-by":"crossref","first-page":"1012799","DOI":"10.3389\/fimmu.2023.1012799","article-title":"Spatiotemporal local and abscopal cell death and immune responses to histotripsy focused ultrasound tumor ablation.","volume":"14","author":"Pepple","year":"2023","journal-title":"Front Immunol"},{"key":"R12-20260711","doi-asserted-by":"crossref","first-page":"113721","DOI":"10.1016\/j.jconrel.2025.113721","article-title":"Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy.","volume":"384","author":"Engelen","year":"2025","journal-title":"J Control Release"},{"key":"R13-20260711","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.3390\/cancers17233773","article-title":"Histotripsy dose impacts treated tumor immune infiltration and survival outcomes in a murine B16F10 melanoma model.","volume":"17","author":"McGinnis","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1 Supplement","key":"R14-20260711","first-page":"224.04","article-title":"Investigating the immunomodulatory effects of histotripsy ablation for osteosarcoma.","volume":"210","author":"Iwanicki","year":"2023","journal-title":"J Immunol"},{"key":"R15-20260711","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/livers4040042","article-title":"Abscopal effect with liver-directed therapy: a review of the current literature and future directions.","volume":"4","author":"Levine","year":"2024","journal-title":"Livers"},{"key":"R16-20260711","doi-asserted-by":"crossref","first-page":"107885","DOI":"10.1016\/j.ultras.2025.107885","article-title":"Histotripsy-mediated reactive oxygen species generation in vitro.","volume":"159","author":"Anthony","year":"2025","journal-title":"Ultrasonics"},{"key":"R17-20260711","first-page":"31348251371287","article-title":"Distant tumor response in the pelvis after histotripsy of a metastatic sarcoma of the liver in a patient with differentiated liposarcoma.","volume":"92","author":"Ong","year":"2025","journal-title":"Am Surg"},{"key":"R18-20260711","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/pharmaceutics17080949","article-title":"Transcriptomic profiling of the immune response in orthotopic pancreatic tumours exposed to combined boiling histotripsy and oncolytic reovirus treatment.","volume":"17","author":"Mouratidis","year":"2025","journal-title":"Pharmaceutics"},{"key":"R21-20260711","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1097\/JS9.0000000000004070","article-title":"First FDA approved experience with histotripsy for liver cancer management.","volume":"112","author":"Soto","year":"2025","journal-title":"Int J Surg"},{"key":"R23-20260711","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00270-025-04183-8","article-title":"Histotripsy of liver metastases: short-term safety and imaging findings.","volume":"48","author":"Mabud","year":"2025","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R24-20260711","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/cancers17071100","article-title":"Histotripsy of liver tumors: patient selection, ethical discussions, and how we do it.","volume":"17","author":"Uysal","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R25-20260711","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1097\/JS9.0000000000003856","article-title":"Prospective analysis on the outcomes of histotripsy for primary and metastatic liver tumours.","volume":"112","author":"Chan","year":"2025","journal-title":"Int J Surg"},{"key":"R26-20260711","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/SLA.0000000000006720","article-title":"The #HOPE4LIVER single-arm pivotal trial for histotripsy of primary and metastatic liver tumors: 1-year update of clinical outcomes.","volume":"282","author":"Ziemlewicz","year":"2025","journal-title":"Ann Surg"},{"key":"R28-20260711","first-page":"364","article-title":"Immune-related adverse events secondary to immunotherapy in oncology: a guide for general practice.","volume":"52","author":"Chisholm","year":"2023","journal-title":"Aust J Gen Pract"},{"key":"R30-20260711","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40164-025-00604-z","article-title":"Bridging therapy with histotripsy prior to liver transplantation for hepatocellular carcinoma: a first case report.","volume":"14","author":"Uysal","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"R31-20260711","doi-asserted-by":"crossref","first-page":"235038","DOI":"10.1088\/1361-6560\/ae222c","article-title":"Aberration correction expands the treatment envelope for histotripsy in the liver.","volume":"70","author":"Yeats","year":"2025","journal-title":"Phys Med Biol"},{"key":"R32-20260711","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.3390\/cancers17152548","article-title":"Breaking barriers with sound: the implementation of histotripsy in cancer.","volume":"17","author":"Raman","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R33-20260711","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1750743X.2024.2442899","article-title":"How could histotripsy change cancer immunotherapy?","volume":"17","author":"Queen","year":"2025","journal-title":"Immunotherapy"},{"key":"R34-20260711","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/jum.70137","article-title":"Boiling histotripsy as a non-invasive non-thermal approach for treatment of human colon cancer tumors: an ex vivo proof-of-concept.","volume":"45","author":"Ponomarchuk","year":"2025","journal-title":"J Ultrasound Med"},{"key":"R35-20260711","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ultrasmedbio.2025.07.026","article-title":"Non-invasive pancreas ablation using histotripsy: pre-clinical safety study in an in vivo porcine model.","volume":"52","author":"Gannon","year":"2025","journal-title":"Ultrasound Med Biol"},{"key":"R36-20260711","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00270-025-04035-5","article-title":"Treatment of primary solid renal tumours using histotripsy: study protocol for the CAIN feasibility trial.","volume":"48","author":"Wah","year":"2025","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R37-20260711","doi-asserted-by":"crossref","first-page":"e230159","DOI":"10.1148\/rycan.230159","article-title":"Advances in tumor management: harnessing the potential of histotripsy.","volume":"6","author":"Verma","year":"2024","journal-title":"Radiol Imaging Cancer"},{"key":"R38-20260711","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/cancers17183072","article-title":"Histotripsy: recent advances, clinical applications, and future prospects.","volume":"17","author":"Pallumeera","year":"2025","journal-title":"Cancers (Basel)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:02:17Z","timestamp":1783778537000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":33,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049082","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"2025-12-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}